Comparing Genetic Risk and Clinical Risk Classification in Luminal-like Breast Cancer Patients Using a 23-Gene Classifier

SIMPLE SUMMARY: Multi-gene expression assays have been advocated for treatment decision in breast cancer management. The most commonly used assays such as Oncotype DX, MammaPrint, which were developed from the Western population, were especially designed for the prognostication of early stage lumina...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chi-Cheng, Chen, Ting-Hao, Liu, Liang-Chih, Huang, Chiun-Sheng, Liang, Ji-An, Hsu, Yu-Chen, Hsieh, Chia-Ming, Huang, Sean-Lin, Shih, Kuan-Hui, Tseng, Ling-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776657/
https://www.ncbi.nlm.nih.gov/pubmed/36551748
http://dx.doi.org/10.3390/cancers14246263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776657/
https://www.ncbi.nlm.nih.gov/pubmed/36551748
http://dx.doi.org/10.3390/cancers14246263

Ejemplares similares